Widespread dermoscopic alterations of multiple melanocytic nevi in a patient receiving vandetanib: implications for dermatological surveillance
Dear Editor, Regression-like dermoscopic and histopathological changes in pre-existing melanocytic nevi have increasingly been reported in patients undergoing modern oncologic therapies, particularly immune checkpoint inhibitors (such as ipilimumab, nivolumab, and pembrolizumab) and targeted agents including BRAF and MEK inhibitors. [...].
Authors
- Giovanni Paolino (ORCID: https://orcid.org/0000-0002-3032-2217)
- Matteo Riccardo Di Nicola (ORCID: https://orcid.org/0000-0001-7199-0804)
- Santo Raffaele Mercuri (ORCID: https://orcid.org/0000-0002-9175-4574)
- Nathalie Rizzo
Institutions
- Vita-Salute San Raffaele University (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
Publication Details
- Journal
- Dermatology Reports
- Published
- 2026-05-12
- DOI
- https://doi.org/10.4081/dr.2026.10851
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00